+100.6%
FLEX vs MRNA
+485.7%
-385.2%
-36.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +7.2% | +5.4% | +1.8% | +7.2% |
| 7D | +5.7% | -1.1% | +6.8% | +5.7% |
| 30D | -7.0% | +126.1% | -133.1% | -5.4% |
| 3M | -23.8% | +190.0% | -213.9% | -27.6% |
| 6M | +82.6% | +157.2% | -74.6% | +75.3% |
| YTD | +91.6% | +388.2% | -296.6% | +65.3% |
| 1Y | +100.6% | +467.0% | -366.5% | +69.8% |
| All | +100.6% | +485.7% | -385.2% | +69.8% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling